19
Nov
HealthCare Global Enterprises Limited (HCG), a leader in cancer care, has partnered with Trucan Diagnostics Pvt Ltd, an innovative startup specializing in cancer diagnostics, to pioneer next-generation diagnostic tests aimed at improving cancer detection and treatment personalization. The collaboration will focus on validating advanced biomarker-driven tests developed by Trucan, which utilize next-generation sequencing to detect primary, recurrent, and metastatic cancers. These tests are designed to predict therapy response before treatment and monitor patient progress during chemotherapy or targeted therapy. The data generated will support integration of these diagnostics into routine clinical practices, enhancing precision oncology capabilities. Dr. B.S. Ajaikumar, Executive…
